SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-16-000176
Filing Date
2016-05-09
Accepted
2016-05-09 08:30:36
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-3311610q.htm 10-Q 906502
2 EXHIBIT 10.1 ligand-vikingxsecondamendm.htm EX-10.1 31840
3 EXHIBIT 31.1 lgnd_33116exhibit311.htm EX-31.1 16490
4 EXHIBIT 31.2 lgnd_33116exhibit312.htm EX-31.2 16387
5 EXHIBIT 32.1 lgnd_33116exhibit321.htm EX-32.1 15608
  Complete submission text file 0000886163-16-000176.txt   6836212

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20160331.xml EX-101.INS 1422599
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20160331.xsd EX-101.SCH 51862
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20160331_cal.xml EX-101.CAL 96213
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20160331_def.xml EX-101.DEF 283289
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20160331_lab.xml EX-101.LAB 823674
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20160331_pre.xml EX-101.PRE 452786
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 161629989
SIC: 2834 Pharmaceutical Preparations